129 related articles for article (PubMed ID: 38522453)
1. 1 in 9 USA cancer diagnoses missed during 2020 COVID-19 pandemic.
Kirby T
Lancet Oncol; 2024 May; 25(5):536. PubMed ID: 38522453
[No Abstract] [Full Text] [Related]
2. Racial and Ethnic Inequities in Cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
[TBL] [Abstract][Full Text] [Related]
3. Study of the Veterans Affairs Health Care System highlights the impact of COVID-19 on cancer diagnoses in the USA.
Parker S
Lancet Oncol; 2022 Jan; 23(1):21. PubMed ID: 34914888
[No Abstract] [Full Text] [Related]
4. New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic.
Kaufman HW; Chen Z; Niles JK; Fesko YA
JCO Clin Cancer Inform; 2022 Oct; 6():e2200102. PubMed ID: 36215672
[No Abstract] [Full Text] [Related]
5. Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
Anderer S
JAMA; 2024 Apr; 331(13):1082. PubMed ID: 38477937
[No Abstract] [Full Text] [Related]
6. During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in England.
Lemanska A; Andrews C; Fisher L; Bacon S; Mehrkar A; Inglesby P; Davy S; Goldacre B; MacKenna B; ; Walker AJ
BJU Int; 2024 May; 133(5):587-595. PubMed ID: 38414224
[TBL] [Abstract][Full Text] [Related]
7. Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.
Labaki C; Bakouny Z; Schmidt A; Lipsitz SR; Rebbeck TR; Trinh QD; Choueiri TK
Cancer Cell; 2021 Aug; 39(8):1042-1044. PubMed ID: 34265251
[No Abstract] [Full Text] [Related]
8. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
[TBL] [Abstract][Full Text] [Related]
9. Missing Diagnoses during the COVID-19 Pandemic: A Year in Review.
Pifarré I Arolas H; Vidal-Alaball J; Gil J; López F; Nicodemo C; Saez M
Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34067807
[TBL] [Abstract][Full Text] [Related]
10. Drop in cancer diagnosis during the COVID-19 pandemic in Denmark: assessment of impact during 2020.
Skovlund CW; Friis S; Christensen J; Nilbert MC; Mørch LS
Acta Oncol; 2022 May; 61(5):658-661. PubMed ID: 35020549
[No Abstract] [Full Text] [Related]
11. COVID-19 and cancer in the United States.
Grob S; Mucci LA
Epidemiol Prev; 2020; 44(5-6 Suppl 2):26-27. PubMed ID: 33412790
[No Abstract] [Full Text] [Related]
12. Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan.
Horita N
Eur J Cancer; 2022 Apr; 165():113-115. PubMed ID: 35231766
[No Abstract] [Full Text] [Related]
13. Trends in Top Cancer Diagnosis and Challenges Related to COVID-19 Pandemic.
Ehrlich H; Sen-Crowe B; McKenney M; Elkbuli A
Am Surg; 2020 Nov; 86(11):1515-1517. PubMed ID: 32856936
[No Abstract] [Full Text] [Related]
14. Impact of the COVID-19 pandemic on time to diagnosis and treatment in children with cancer at tertiary care level.
Dufour L; Simon A; Murray MJ; Behjati S
Arch Dis Child; 2022 Sep; 107(9):851. PubMed ID: 35918139
[No Abstract] [Full Text] [Related]
15. A collateral effect of the COVID-19 pandemic: Delayed diagnosis in pediatric solid tumors.
Chiaravalli S; Ferrari A; Sironi G; Gattuso G; Bergamaschi L; Puma N; Schiavello E; Biassoni V; Podda M; Meazza C; Spreafico F; Casanova M; Terenziani M; Luksch R; Massimino M
Pediatr Blood Cancer; 2020 Oct; 67(10):e28640. PubMed ID: 32761998
[No Abstract] [Full Text] [Related]
16. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
[TBL] [Abstract][Full Text] [Related]
17. The impact of the COVID-19 pandemic on cancer screening.
Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N
Eur J Cancer Prev; 2022 Sep; 31(5):487-488. PubMed ID: 34456263
[No Abstract] [Full Text] [Related]
18. Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic.
Ding YY; Ramakrishna S; Long AH; Phillips CA; Montiel-Esparza R; Diorio CJ; Bailey LC; Maude SL; Aplenc R; Batra V; Reilly AF; Rheingold SR; Lacayo NJ; Sakamoto KM; Hunger SP
Pediatr Blood Cancer; 2020 Sep; 67(9):e28427. PubMed ID: 32588960
[No Abstract] [Full Text] [Related]
19. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic.
Kaufman HW; Chen Z; Niles J; Fesko Y
JAMA Netw Open; 2020 Aug; 3(8):e2017267. PubMed ID: 32749465
[TBL] [Abstract][Full Text] [Related]
20. Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark.
Skovlund CW; Friis S; Dehlendorff C; Nilbert MC; Mørch LS
Acta Oncol; 2021 Jan; 60(1):20-23. PubMed ID: 33287604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
